(Q50796108)

English

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.

scientific article published on 24 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

atherosclerosis

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

12

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

author name string

M Olukman

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

C Koulis

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

Y Tu

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

D Samijono

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

D Yuen

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

C Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

D J Behm

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

M E Cooper

9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

K A M Jandeleit-Dahm

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

A C Calkin

11

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

publication date

24 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

56

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

1155-1165

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

https://scigraph.springernature.com/pub.10.1007/s00125-013-2837-9

0 references

Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II: the old kid in town.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Increased plasma urotensin II levels in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Role of prostaglandins in urotensin II-induced vasodilatation in the coronary arteries of aged rats

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Antioxidants in the treatment of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A noninvasive computerized tail-cuff system for measuring blood pressure in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-013-2837-9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/23344731

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50796108&oldid=1416659000"